Direkt zum Inhalt
Merck
  • Effect of activated autologous platelet-rich plasma on proliferation and osteogenic differentiation of human adipose-derived stem cells in vitro.

Effect of activated autologous platelet-rich plasma on proliferation and osteogenic differentiation of human adipose-derived stem cells in vitro.

American journal of translational research (2015-04-23)
Fang-Tian Xu, Hong-Mian Li, Qing-Shui Yin, Zhi-Jie Liang, Min-Hong Huang, Guang-Yi Chi, Lu Huang, Da-Lie Liu, Hua Nan
ZUSAMMENFASSUNG

To investigate whether activated autologous platelet-rich plasma (PRP) can promote proliferation and osteogenic differentiation of human adipose-derived stem cells (hASCs) in vitro. hASCs were isolated from lipo-aspirates, and characterized by specific cell markers and multilineage differentiation capacity after culturing to the 3(rd) passage. PRP was collected and activated from human peripheral blood of the same patient. Cultured hASCs were treated with normal osteogenic inductive media alone (group A, control) or osteogenic inductive media plus 5%, 10%, 20%, 40%PRP (group B, C, D, E, respectively). Cell proliferation was assessed by CCK-8 assay. mRNA expression of osteogenic marker genes including alkaline phosphatase (ALP), osteopontin (OPN), osteocalcin (OCN) and core binding factor alpha 1 (Cbfa1) were determined by Real-Time Quantitative PCR Analysis (qPCR). Data revealed that different concentrations of activated autologous PRP significantly promoted hASCs growth in the proliferation phase compared to the without PRP group and resulted in a dose-response relationship. At 7-d and 14-d time point of the osteogenic induced stage, ALP activity in PRP groups gradually increased with the increasing of concentrations of PRP and showed that dose-response relationship. At 21-d time point of the osteogenic induced stage, PRP groups make much more mineralization and mRNA relative expression of ALP, OPN, OCN and Cbfa1 than that without PRP groups and show that dose-response relationship. This study indicated that different concentrations of activated autologous PRP can promote cell proliferation at earlier stage and promote osteogenic differentiation at later stage of hASCs in vitro. Moreover, it displayed a dose-dependent effect of activated autologous PRP on cell proliferation and osteogenic differentiation of hASCs in vitro.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Dexamethason, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
Calciumchlorid -Lösung, BioUltra, Molecular Biology, ~1 M in H2O
Sigma-Aldrich
Calciumchlorid, anhydrous, BioReagent, suitable for insect cell culture, suitable for plant cell culture, ≥96.0%
Sigma-Aldrich
4-Nitrophenol, ReagentPlus®, ≥99%
Sigma-Aldrich
Dexamethason, ≥98% (HPLC), powder
Sigma-Aldrich
Calciumchlorid, powder, 99.99% trace metals basis
Sigma-Aldrich
Calciumchlorid Dihydrat
Supelco
Dexamethason, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Cetylpyridiniumchlorid, meets USP testing specifications
Sigma-Aldrich
4-Nitrophenol -Lösung, 10 mM
Sigma-Aldrich
Dexamethason, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
Calciumchlorid, AnhydroBeads, −10 mesh, ≥99.9% trace metals basis
USP
Dexamethason, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
4-Nitrophenol, spectrophotometric grade
Supelco
Calcium Standard für AAS, analytical standard, 1.000 g/L Ca2+ in hydrochloric acid, traceable to BAM
Sigma-Aldrich
Dexamethason, meets USP testing specifications
USP
Cetylpyridiniumchlorid, United States Pharmacopeia (USP) Reference Standard
Supelco
4-Nitrophenol, PESTANAL®, analytical standard
Sigma-Aldrich
Edelfosine, ≥95% (HPLC)
Supelco
Acetaminophen-verwandte Verbindung F, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Calcium Ionenlösung für ISE, 0.1 M Ca, analytical standard (for ion-selective electrodes)
Sigma-Aldrich
Calciumchlorid, AnhydroBeads, −10 mesh, ≥99.99% trace metals basis
Cetylpyridiniumchlorid, European Pharmacopoeia (EP) Reference Standard
Dexamethason, European Pharmacopoeia (EP) Reference Standard
Supelco
Dexamethason, VETRANAL®, analytical standard
Sigma-Aldrich
Dexamethason, tested according to Ph. Eur.
Dexamethason, British Pharmacopoeia (BP) Assay Standard
Dexamethason für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard
Dexamethason für die Systemeignung, European Pharmacopoeia (EP) Reference Standard